Cargando…

Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report

BACKGROUND: Hepatocellular carcinoma (HCC) may be caused by hepatitis B virus (HBV) infection. Post-infection recovery-associated changes of HBV indicators include decreased hepatitis B surface antigen (HBsAg) level and increased anti-HBsAg antibody titer. Testing to detect HBV DNA is conducted rare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jing-Jing, Chen, Yu, Nan, Yu-Chen, Yang, Yong-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554442/ https://www.ncbi.nlm.nih.gov/pubmed/34754858 http://dx.doi.org/10.12998/wjcc.v9.i28.8492

Ejemplares similares

Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer.
por: Macnab, G. M., et al.
Publicado: (1976)

Correlation Between Hepatitis B Surface Antigen Titers and HBV DNA Levels
por: Alghamdi, Amal, et al.
Publicado: (2013)

Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients
por: Liang, Ling-Bo, et al.
Publicado: (2015)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
por: Kaur, Satinder P., et al.
Publicado: (2022)

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1996)

Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age
por: Dabrowska-Leonik, Nel, et al.
Publicado: (2022)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
por: Lee, Han Ah, et al.
Publicado: (2016)

Hepatitis B virus vaccination of voluntary blood donors and immunization status assessment by Anti-Hepatitis B Surface (HBs) antibody titer
por: Singh, R. P., et al.
Publicado: (2013)

Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults
por: Kakisaka, Keisuke, et al.
Publicado: (2019)

Assessment of antibody titers and immunity to Hepatitis B in children receiving chemotherapy
por: Shams Shahemabadi, A, et al.
Publicado: (2012)

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies
por: Yağcı, Münci, et al.
Publicado: (2015)

Correlation between Hepatitis B Surface Antigen Titers and HBV DNA Levels: What about the Parameters Affecting this Correlation?
por: Karagoz, Ergenekon, et al.
Publicado: (2014)

Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up
por: Verso, Maria Gabriella, et al.
Publicado: (2020)

Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis
por: Song, Aixin, et al.
Publicado: (2021)

Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
por: Park, Yewan, et al.
Publicado: (2021)

Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
por: Kim, Sung Eun
Publicado: (2017)

Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
por: Tian, Xiaochen, et al.
Publicado: (2009)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
por: Jang, Jeong Won, et al.
Publicado: (2021)

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
por: Yu, Ming-Whei, et al.
Publicado: (2022)

Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
por: Lee, Hyun Woong, et al.
Publicado: (2020)

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen– and antibody to hepatitis B core antigen–positive donor
por: Blaich, Annette, et al.
Publicado: (2012)

Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation
por: Lou, Bin, et al.
Publicado: (2021)

Hepatitis B Virus Surface Antigen Promotes Stemness of Hepatocellular Carcinoma through Regulating MicroRNA-203a
por: Qin, Yu-Fei, et al.
Publicado: (2023)

Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients
por: Kim, Jong Hun, et al.
Publicado: (2012)

A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection
por: Zeng, Da-Wu, et al.
Publicado: (2016)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
por: Chen, Zhitao, et al.
Publicado: (2023)

Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma.
por: Kew, M. C., et al.
Publicado: (1980)

State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection
por: Schemmer, Peter, et al.
Publicado: (2021)

Hepatitis B Virus and Primary Hepatocellular Carcinoma
por: Sutton, R. N. P.
Publicado: (1982)

Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains
Publicado: (1993)

Hepatitis B virus core antigen mutations predict post-operative prognosis of patients with primary hepatocellular carcinoma
por: Jia, Jian’an, et al.
Publicado: (2017)

Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
por: Li, Ming-Hui, et al.
Publicado: (2017)

Geographic correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece.
por: Trichopoulos, D., et al.
Publicado: (1976)

Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs
por: Novellino, Luisa, et al.
Publicado: (2012)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
por: Gök Sargın, Zeynep
Publicado: (2023)

Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976.
por: Gibson, J. B., et al.
Publicado: (1980)

Clinical characteristics and plasma antibody titer of patients with COVID-19 in Zhejiang, China
por: Xiang, Wei-ling, et al.
Publicado: (2020)

Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B
por: Li, Ming-Hui, et al.
Publicado: (2018)

Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
por: He, Ziming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3v3p20qp8rdj4tdljhl2lbup56